Detalhe da pesquisa
1.
Achievement of the National Psoriasis Foundation treatment targets with ixekizumab: Pooled analyses from 4 clinical studies.
J Am Acad Dermatol
; 85(2): 330-336, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31562945
2.
Comparison of cumulative clinical benefits of biologics for the treatment of psoriasis over 16 weeks: Results from a network meta-analysis.
J Am Acad Dermatol
; 82(5): 1138-1149, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31884091
3.
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
N Engl J Med
; 375(4): 345-56, 2016 Jul 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27299809
4.
Sick and unsheltered: Homelessness as a major risk factor for emergency care utilization.
Am J Emerg Med
; 37(3): 415-420, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29891125
5.
Dermatologists: Collaborating With Payers to Optimize Coverage Policies.
J Drugs Dermatol
; 16(3): 228-232, 2017 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28301618
6.
Ixekizumab Is Effective in Subjects With Moderate to Severe Plaque Psoriasis With Significant Nail Involvement: Results From UNCOVER 3.
J Drugs Dermatol
; 15(8): 958-61, 2016 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27537996
7.
Changes in plasma and urine globotriaosylceramide levels do not predict Fabry disease progression over 1 year of agalsidase alfa.
Genet Med
; 15(12): 983-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23680766
8.
Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial.
J Drugs Dermatol
; 12(8): 874-80, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23986160
9.
Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: a randomized controlled trial.
JAMA
; 302(23): 2557-64, 2009 Dec 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20009055
10.
Evaluation of sPGA × BSA as an Outcome Measure and Treatment Target for Clinical Practice.
J Invest Dermatol
; 138(9): 1955-1961, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29577919
11.
Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations.
Sleep
; 30(8): 959-68, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17702264
12.
A pilot study evaluating acute use of eszopiclone in patients with mild to moderate obstructive sleep apnea syndrome.
Sleep Med
; 8(5): 464-70, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17512799
13.
Cost per additional responder for ixekizumab and other FDA-approved biologics in moderate-to-severe plaque psoriasis.
J Med Econ
; 20(12): 1224-1230, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28760056
14.
Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
Biol Psychiatry
; 59(11): 1052-60, 2006 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16581036
15.
Effect of Ixekizumab Treatment on Work Productivity for Patients With Moderate-to-Severe Plaque Psoriasis: Analysis of Results From 3 Randomized Phase 3 Clinical Trials.
JAMA Dermatol
; 152(6): 661-9, 2016 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26953848
16.
A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia.
Sleep
; 28(6): 720-7, 2005 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16477959
17.
An assessment of the efficacy and safety of eszopiclone in the treatment of transient insomnia in healthy adults.
Sleep Med
; 6(1): 15-22, 2005 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-15680290
18.
Immunogenicity of idursulfase and clinical outcomes in very young patients (16 months to 7.5 years) with mucopolysaccharidosis II (Hunter syndrome).
Orphanet J Rare Dis
; 10: 50, 2015 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-25902842
19.
Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia.
Sleep
; 26(7): 793-9, 2003 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14655910
20.
Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia.
Curr Med Res Opin
; 20(12): 1979-91, 2004 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-15701215